BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3098704)

  • 1. Chelating agents for the binding of metal ions to antibodies.
    Meares CF
    Int J Rad Appl Instrum B; 1986; 13(4):311-8. PubMed ID: 3098704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.
    Meares CF; McCall MJ; Reardan DT; Goodwin DA; Diamanti CI; McTigue M
    Anal Biochem; 1984 Oct; 142(1):68-78. PubMed ID: 6440451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chelated metal ions for therapeutic and diagnostic applications.
    Brechbiel MW
    Exp Biol Med (Maywood); 2001 Jul; 226(7):627-8. PubMed ID: 11444098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary. New developments in metal antidotal properties of chelating agents.
    Catsch A; Harmuth-Hoene AE
    Biochem Pharmacol; 1975 Sep; 24(17):1557-62. PubMed ID: 811227
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of important residues in metal-chelate recognition by monoclonal antibodies.
    Delehanty JB; Jones RM; Bishop TC; Blake DA
    Biochemistry; 2003 Dec; 42(48):14173-83. PubMed ID: 14640685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibody-linked chelating polymers for nuclear therapy and diagnostics.
    Torchilin VP; Klibanov AL
    Crit Rev Ther Drug Carrier Syst; 1991; 7(4):275-308. PubMed ID: 2040018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of LD50 of some polyaminocarboxylic acids used as chelating drugs in metal intoxication.
    Srivastava RC; Dwivedi PP; Behari JR; Athar M
    Toxicol Lett; 1986; 32(1-2):37-40. PubMed ID: 3090738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labeling of monoclonal antibodies with radionuclides.
    Bhargava KK; Acharya SA
    Semin Nucl Med; 1989 Jul; 19(3):187-201. PubMed ID: 2503873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chelating agents.
    Bergan T; Klaveness J; Aasen AJ
    Chemotherapy; 2001; 47(1):10-4. PubMed ID: 11125227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chelating agents on the excretion of endogenous metals.
    Cantilena LR; Klaassen CD
    Toxicol Appl Pharmacol; 1982 May; 63(3):344-50. PubMed ID: 6285552
    [No Abstract]   [Full Text] [Related]  

  • 11. New chelating agent for attaching indium-111 to monoclonal antibodies: in vitro and in vivo evaluation.
    Subramanian R; Colony J; Shaban S; Sidrak H; Haspel MV; Pomato N; Hanna MG; McCabe RP
    Bioconjug Chem; 1992; 3(3):248-55. PubMed ID: 1520729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo removal of a few heavy metals in certain tissues of the fish Notopterus notopterus.
    Verma SR; Jain M; Dalela RC
    Environ Res; 1981 Dec; 26(2):328-34. PubMed ID: 6274630
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.
    Westerberg DA; Carney PL; Rogers PE; Kline SJ; Johnson DK
    J Med Chem; 1989 Jan; 32(1):236-43. PubMed ID: 2491892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How the anti-(metal chelate) antibody CHA255 is specific for the metal ion of its antigen: X-ray structures for two Fab'/hapten complexes with different metals in the chelate.
    Love RA; Villafranca JE; Aust RM; Nakamura KK; Jue RA; Major JG; Radhakrishnan R; Butler WF
    Biochemistry; 1993 Oct; 32(41):10950-9. PubMed ID: 8218161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide and hydrogen peroxide suppression by metal ions and their EDTA complexes.
    Fisher AE; Maxwell SC; Naughton DP
    Biochem Biophys Res Commun; 2004 Mar; 316(1):48-51. PubMed ID: 15003509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advance in the therapy of metal poisoning with complexing agents].
    Aaseth J
    Tidsskr Nor Laegeforen; 1972 May; 12(13):918-22. PubMed ID: 4624035
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
    Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR
    J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
    Faivre-Chauvet A; Mease RC; Chetanneau A; Bardiès M; Sai-Maurel C; Meinken GE; Srivastava SC; Chatal JF; Gestin JF
    Nucl Med Commun; 1996 Sep; 17(9):781-9. PubMed ID: 8895905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of the first diethylenetriaminepentahydroxamic acid (DTPH) bifunctional chelating agent.
    Safavy A; Smith DC; Bazooband A; Buchsbaum DJ
    Bioconjug Chem; 2002; 13(2):327-32. PubMed ID: 11906271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry of carcinogenic metals.
    Martell AE
    Environ Health Perspect; 1981 Aug; 40():207-26. PubMed ID: 6791915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.